HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case report of anesthesia for a child with Pompe's disease (glycogen storage disease type II)].

Abstract
A case report of a child with Pompe's disease (glycogen storage disease type II), who underwent two general anesthetics, is presented. The progressive infiltration of heart and skeletal muscle with glycogen results in a severe form of cardiomyopathy and respiratory muscle weakness. Death usually occurs by 1 year of age from respiratory insufficiency or end-stage cardiomyopathy. Consequently, there are significant problems in the anesthetic management of these patients. The patient, a female child of 6 months presented signs of cardiac failure and took treatment with olprinone and diuretic. The initial surgical procedure was placement of a subcutaneous central venous catheter. Anesthesia was induced with ketamine and midazolam intravenously, and was maintained with nitrous oxide (50%) and intravenous ketamine. The dosage of the dopamine and olprinone was necessary to maintain circulation. For tracheotomy, the second procedure, anesthesia was induced and maintained with sevoflurane and dopamine. Recently a promising enzyme replacement therapy has resulted in improved clinical outcomes, and the number of anesthesia for infants of with Pompe's disease will increase in future.
AuthorsMichiko Sakakibara, Yuzo Teramoto, Tadashi Aoyama, Tetsuyuki Takahashi, Masato Hara, Megumi Maseki, Shinya Yamaguchi, Jun Nakata
JournalMasui. The Japanese journal of anesthesiology (Masui) Vol. 58 Issue 2 Pg. 219-22 (Feb 2009) ISSN: 0021-4892 [Print] Japan
PMID19227183 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Anesthesia, General (methods)
  • Catheterization, Central Venous
  • Female
  • Glycogen Storage Disease Type II (complications)
  • Humans
  • Infant
  • Tracheotomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: